Is Sisram Medical still competitive with InMode and Cutera?

Sisram remains a credible alternative, but faces margin compression in Western markets where InMode and Cutera dominate. The company is offsetting this through aggressive Asia-Pacific expansion, though its long-term competitive position depends on sustaining growth outside mature geographies.

What laser platforms does Sisram Medical offer through Alma and Cutera?

Sisram's portfolio includes Alma Lasers (diode, alexandrite, Nd:YAG, and RF platforms) and Cutera devices (Xeo, Secret Pro, Prolite). These span multiple wavelengths and modalities for hair removal, skin resurfacing, and aesthetic treatments.

Why are medical device margins compressing in North America and Europe?

Western markets are consolidating around a few dominant players, driving competitive pricing pressure and market saturation. APAC emerging markets offer higher growth rates and less price competition, which is why device makers like Sisram are pivoting geographically.

How should med spa owners respond to tightening device economics?

Practices must optimize utilization rates and pricing strategies to maintain ROI as gross margins compress. Device economics are tightening across the industry, making operational efficiency and strategic pricing critical to profitability.

What does Sisram's H1 2026 performance tell us about the med spa device market?

Strong APAC growth offsetting Western margin pressure signals that the industry is bifurcating—mature markets are consolidating while emerging markets offer expansion opportunities. This trend suggests device competition will intensify in the West while new markets remain less saturated.

Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →

RegulatoryAbbVie Launches Phase 2 Forehead Lines Studytoday MarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days ago Business & M&AAllergan Aesthetics Overhauls Loyalty Programtoday Devices & TechXERF Technology Enters Australian Market for Skin Tightening2 days ago Business & M&AEvolus Expands Estyme to Canada, Australia, New Zealandtoday MarketArm Fat Now Top Body Sculpting Concern in Singapore2 days ago Devices & TechSofwave Hits One Million Treatments Milestonetoday RegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days ago RegulatoryRevance Wins FDA Nod for Under-Eye Injectablesyesterday MarketGLP-1 Pill Era Is Forcing Beauty Market Shiftyesterday InjectablesAEON Releases Expanded ABP-450 Botox Biosimilar Datayesterday Devices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday

Devices & Tech

Sisram Medical H1 2026: APAC Growth Offsets Margin Pressure

The energy-device maker posts solid interim results as Asia-Pacific expansion compensates for Western margin compression.

By Evan at Inside MedSpa · Aug 21, 2026

1-YEAR MOVE

INMD ▲1.0%

1-year price move by ticker
Ticker	Company	1-year change
INMD	InMode Ltd.	+1.0%

Sisram Medical reported H1 2026 results showing strong growth in Asia-Pacific markets, offsetting margin pressure in mature Western geographies. The company's device portfolio—including Alma Lasers (diode, alexandrite, Nd:YAG, and RF platforms) and Cutera (Xeo, Secret Pro, Prolite)—continues to drive revenue, though profitability has compressed as competitive pricing and market saturation weigh on gross margins.

Inside MedSpa Pro

You've reached your free articles this week.

Keep reading every article, unlock the full trackers, and get the twice-a-week intelligence brief — from $20/mo, or $200/yr (two months free). Never miss a recall or a rule change.

Every article, unlocked — no weekly limit
The full 50-state law tracker, stock & M&A watch
The twice-a-week, 2-minute intelligence brief
Recalls, FDA clearances & safety signals as they hit

See everything you get →

Cancel anytime, one click · 14-day money-back on annual

https://insidemedspa.com/article/sisram-medical-h1-2026-apac-growth/

Discussion

Free alerts

Get flagged before it costs you.

We'll flag the moment a recall or rule change hits your practice. One email a week, one click to leave.

Free · weekly · unsubscribe anytime. Privacy.

This morning's brief · 6 AM

The free version stops here.

What today's moves mean for your margins — and exactly what to do — already went out to Pro. By the time the trade press explains it, the window to act has closed.

Go Pro · $20/mo Two minutes a morning. Cancel anytime.

Live · Market movers

STRATA Skin Sciences-50%Hims & Hers Health+6.03%Estée Lauder+6.02%Bausch Health (Solta)-5.43%The Beauty Health Company (HydraFacial)+3.65%

The full stock & M&A watch →

FDA Activity — Aesthetic Devices

Monthly 510(k) clearances vs. recalls.

510(k) clearances Recalls

FDA Activity — Aesthetic Devices — Monthly 510(k) clearances vs. recalls.
Month	510(k) clearances	Recalls
Jun '25	0	4
Jul '25	0	1
Sep '25	0	1
Oct '25	0	2
Jan '26	0	1
Feb '26	0	5
Mar '26	0	5
Apr '26	0	19
May '26	7	18
Jun '26	34	8
Jul '26	23	4
Aug '26	5	0

The 50-state regulation tracker →

Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.

The twice-a-week intelligence brief Go Pro · $20/mo →

Sisram Medical H1 2026: APAC Growth Offsets Margin Pressure

Share

Discussion

Leave a comment

By the time it's news, it's too late.